We developed an innovative artificial intelligence system for precision oncology medicine.
Every year, millions face the devastating diagnosis of cancer, often enduring invasive treatments with significant side effects. At KeyZell, we have developed LZ-167, a groundbreaking drug designed to:
Provide an accesible and scalable solution worldwide.